PMC:7574920 / 19252-19597
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T100 | 329-332 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T62 | 245-247 | Disease | denotes | OD | http://purl.obolibrary.org/obo/MONDO_0017178 |
| T63 | 318-326 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T192 | 96-98 | http://purl.obolibrary.org/obo/CLO_0001000 | denotes | 35 |
| T193 | 110-112 | http://purl.obolibrary.org/obo/CLO_0001000 | denotes | 35 |
| T194 | 229-230 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T195 | 258-259 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 204 | 318-328 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T112 | 16-18 | http://purl.obolibrary.org/obo/GO_0001171 | denotes | RT |
| T113 | 44-46 | http://purl.obolibrary.org/obo/GO_0001171 | denotes | RT |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T123 | 16-23 | Sentence | denotes | RT-LAMP |
| T124 | 24-43 | Sentence | denotes | CT Pos Neg Sum |
| T125 | 44-75 | Sentence | denotes | RT-qPCR Pos 0–25 51 0 51 |
| T126 | 76-92 | Sentence | denotes | 25–30 28 2 30 |
| T127 | 93-109 | Sentence | denotes | 30–35 4 16 20 |
| T128 | 110-126 | Sentence | denotes | 35–40 0 16 16 |
| T129 | 127-149 | Sentence | denotes | Neg Neg 2 649 651 |
| T130 | 150-343 | Sentence | denotes | Sum 85 683 768 The consistency of the results during the analysis confirmed a threshold of ΔOD > +0.3 as a robust measure to identify samples that were positive for SARS-CoV-2 RNA (Fig. 3A). |